Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population.
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2016
At a glance
- Drugs Atazanavir (Primary) ; Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 05 Jan 2016 Results published in the Antiviral Therapy
- 05 Jun 2012 Planned end date changed from 1 May 2012 to 1 May 2014 as reported by ClinicalTrials.gov.
- 14 Apr 2011 Planned End Date changed from 1 May 2011 to 1 May 2012, according to ClinicalTrials.gov.